These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21304506)

  • 21. Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response.
    Potter C; Gibbons LJ; Bowes JD; Cordell HJ; Hyrich K; Isaacs JD; Morgan AW; Wilson AG; Barton A;
    Pharmacogenet Genomics; 2010 May; 20(5):338-41. PubMed ID: 20300049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized medicine in rheumatoid arthritis: miles to go before we sleep.
    Plenge RM; Bridges SL
    Arthritis Rheum; 2011 Mar; 63(3):590-3. PubMed ID: 21360486
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
    Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD
    Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.
    Julià A; Fernandez-Nebro A; Blanco F; Ortiz A; Cañete JD; Maymó J; Alperi-López M; Fernández-Gutierrez B; Olivè A; Corominas H; Erra A; Acosta-Colman I; Alonso A; López-Lasanta M; Tortosa R; Tornero J; Marsal S
    Pharmacogenomics J; 2016 Apr; 16(2):147-50. PubMed ID: 25896534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].
    Taniguchi A; Urano W; Tanaka E; Kamatani N
    Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.
    Avila-Pedretti G; Tornero J; Fernández-Nebro A; Blanco F; González-Alvaro I; Cañete JD; Maymó J; Alperiz M; Fernández-Gutiérrez B; Olivé A; Corominas H; Erra A; Aterido A; López Lasanta M; Tortosa R; Julià A; Marsal S
    PLoS One; 2015; 10(4):e0122088. PubMed ID: 25848939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: SNPs of drug metabolic enzymes and personalized medicine Part II.
    Wei DQ; Chen Q
    Curr Drug Metab; 2012 Sep; 13(7):951. PubMed ID: 22475268
    [No Abstract]   [Full Text] [Related]  

  • 28. GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis.
    Acosta-Colman I; Palau N; Tornero J; Fernández-Nebro A; Blanco F; González-Alvaro I; Cañete JD; Maymó J; Ballina J; Fernández-Gutiérrez B; Olivé A; Corominas H; Erra A; Canela-Xandri O; Alonso A; López Lasanta M; Tortosa R; Julià A; Marsal S
    Pharmacogenomics; 2013 May; 14(7):727-34. PubMed ID: 23651021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
    Bodio C; Grossi C; Pregnolato F; Favalli EG; Biggioggero M; Marchesoni A; Murgo A; Filippini M; Migliorini P; Caporali R; Pellerito R; Ciccia F; Sarzi-Puttini P; Perosa F; Paolazzi G; Hollan I; Bendtzen K; Meroni PL; Borghi MO
    Autoimmun Rev; 2020 May; 19(5):102509. PubMed ID: 32173513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics in treatment of rheumatoid arthritis.
    Kooloos WM; Huizinga TW; Guchelaar HJ; Wessels JA
    Curr Pharm Des; 2010; 16(2):164-75. PubMed ID: 20205662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis.
    Pallio G; Mannino F; Irrera N; Eid AH; Squadrito F; Bitto A
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32825059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and genomic predictors of anti-TNF response.
    Prajapati R; Plant D; Barton A
    Pharmacogenomics; 2011 Nov; 12(11):1571-85. PubMed ID: 22044414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study.
    Suarez-Gestal M; Perez-Pampin E; Calaza M; Gomez-Reino JJ; Gonzalez A
    Arthritis Res Ther; 2010; 12(2):R72. PubMed ID: 20423481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
    Fabris M; Tolusso B; Di Poi E; Assaloni R; Sinigaglia L; Ferraccioli G
    J Rheumatol; 2002 Sep; 29(9):1847-50. PubMed ID: 12233877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future prospects for pharmacogenetics in the quest for personalized medicine.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis.
    Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2015; 10(10):e0139781. PubMed ID: 26440629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.
    Canet LM; Filipescu I; Cáliz R; Lupiañez CB; Canhão H; Escudero A; Segura-Catena J; Soto-Pino MJ; Ferrer MA; García A; Romani L; Pérez-Pampin E; González-Utrilla A; López Nevot MA; Collantes E; Fonseca JE; Sainz J
    Pharmacogenet Genomics; 2015 Jul; 25(7):323-33. PubMed ID: 25850964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
    Tan RJ; Gibbons LJ; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Ann Rheum Dis; 2010 Jun; 69(6):1029-35. PubMed ID: 20444755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis.
    Umićević Mirkov M; Janss L; Vermeulen SH; van de Laar MA; van Riel PL; Guchelaar HJ; Brunner HG; Albers CA; Coenen MJ
    Ann Rheum Dis; 2015 Dec; 74(12):2183-7. PubMed ID: 25114059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis.
    Lee YH; Rho YH; Choi SJ; Ji JD; Song GG
    Rheumatol Int; 2006 Dec; 27(2):157-61. PubMed ID: 16909270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.